Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wound Healing | 22 | 2023 | 452 | 3.930 |
Why?
|
| Interleukin-10 | 11 | 2023 | 172 | 3.560 |
Why?
|
| Hyaluronic Acid | 7 | 2021 | 95 | 2.070 |
Why?
|
| Cicatrix | 4 | 2023 | 125 | 1.810 |
Why?
|
| Fibroblasts | 8 | 2021 | 884 | 1.750 |
Why?
|
| Neovascularization, Physiologic | 8 | 2022 | 211 | 1.500 |
Why?
|
| Endothelial Progenitor Cells | 2 | 2022 | 11 | 1.310 |
Why?
|
| Lignin | 2 | 2023 | 12 | 1.040 |
Why?
|
| Gene Transfer Techniques | 5 | 2015 | 357 | 0.900 |
Why?
|
| Skin | 5 | 2023 | 507 | 0.890 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2015 | 135 | 0.830 |
Why?
|
| Wound Infection | 5 | 2022 | 51 | 0.790 |
Why?
|
| Surgical Wound | 1 | 2022 | 24 | 0.790 |
Why?
|
| Hymecromone | 1 | 2021 | 5 | 0.780 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2021 | 26 | 0.770 |
Why?
|
| STAT3 Transcription Factor | 3 | 2022 | 216 | 0.740 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 182 | 0.710 |
Why?
|
| Antioxidants | 1 | 2023 | 338 | 0.710 |
Why?
|
| Fetal Development | 3 | 2015 | 112 | 0.640 |
Why?
|
| Mice | 24 | 2023 | 17562 | 0.600 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2018 | 28 | 0.600 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 850 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 14 | 2023 | 4369 | 0.560 |
Why?
|
| Animals | 31 | 2023 | 33859 | 0.550 |
Why?
|
| NF-kappa B | 2 | 2018 | 458 | 0.540 |
Why?
|
| Hyperoxia | 1 | 2018 | 127 | 0.530 |
Why?
|
| Extracellular Matrix | 6 | 2020 | 232 | 0.510 |
Why?
|
| Angiopoietin-1 | 1 | 2015 | 7 | 0.510 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2015 | 21 | 0.500 |
Why?
|
| Signal Transduction | 3 | 2020 | 4501 | 0.500 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2018 | 187 | 0.500 |
Why?
|
| Dependovirus | 3 | 2013 | 129 | 0.500 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2015 | 342 | 0.500 |
Why?
|
| Pseudomonas Infections | 3 | 2022 | 116 | 0.490 |
Why?
|
| Nanofibers | 2 | 2011 | 15 | 0.480 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2022 | 413 | 0.470 |
Why?
|
| Gene Expression | 1 | 2018 | 1566 | 0.440 |
Why?
|
| Cells, Cultured | 8 | 2019 | 3046 | 0.410 |
Why?
|
| Cytomegalovirus | 1 | 2014 | 269 | 0.400 |
Why?
|
| Genetic Vectors | 2 | 2013 | 939 | 0.400 |
Why?
|
| Viral Proteins | 1 | 2014 | 350 | 0.390 |
Why?
|
| Adenoviridae | 2 | 2015 | 604 | 0.390 |
Why?
|
| Skin Ulcer | 1 | 2011 | 32 | 0.380 |
Why?
|
| Lung | 2 | 2018 | 1465 | 0.370 |
Why?
|
| Proteolysis | 1 | 2011 | 163 | 0.360 |
Why?
|
| Tissue Engineering | 2 | 2011 | 176 | 0.360 |
Why?
|
| Vagina | 2 | 2023 | 199 | 0.350 |
Why?
|
| Estrogens | 2 | 2023 | 512 | 0.330 |
Why?
|
| Pulmonary Fibrosis | 2 | 2020 | 96 | 0.300 |
Why?
|
| Immune Tolerance | 2 | 2019 | 145 | 0.280 |
Why?
|
| Keratinocytes | 3 | 2016 | 60 | 0.270 |
Why?
|
| Cell Movement | 3 | 2015 | 831 | 0.270 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2022 | 166 | 0.230 |
Why?
|
| Amnion | 1 | 2023 | 38 | 0.210 |
Why?
|
| Kidney | 2 | 2020 | 1343 | 0.210 |
Why?
|
| Bandages | 2 | 2020 | 55 | 0.210 |
Why?
|
| Biofilms | 2 | 2022 | 91 | 0.210 |
Why?
|
| Molecular Weight | 2 | 2020 | 392 | 0.200 |
Why?
|
| Inovirus | 1 | 2022 | 2 | 0.200 |
Why?
|
| Culture Media, Conditioned | 1 | 2022 | 79 | 0.200 |
Why?
|
| Inflammation | 4 | 2022 | 1405 | 0.200 |
Why?
|
| Hydrogels | 2 | 2021 | 78 | 0.200 |
Why?
|
| Propylene Glycol | 1 | 2021 | 8 | 0.200 |
Why?
|
| Administration, Cutaneous | 1 | 2021 | 65 | 0.190 |
Why?
|
| Collagen | 1 | 2023 | 317 | 0.190 |
Why?
|
| Dermis | 1 | 2021 | 24 | 0.190 |
Why?
|
| Gelatin | 1 | 2021 | 15 | 0.190 |
Why?
|
| Water | 1 | 2021 | 182 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 353 | 0.180 |
Why?
|
| Financing, Organized | 1 | 2020 | 19 | 0.180 |
Why?
|
| Skin Care | 1 | 2020 | 14 | 0.180 |
Why?
|
| Ethanol | 1 | 2021 | 161 | 0.180 |
Why?
|
| Dermatologic Agents | 1 | 2020 | 31 | 0.170 |
Why?
|
| Debridement | 1 | 2020 | 85 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2019 | 810 | 0.170 |
Why?
|
| Writing | 1 | 2020 | 62 | 0.160 |
Why?
|
| Oxygen | 1 | 2023 | 550 | 0.160 |
Why?
|
| Gastrostomy | 1 | 2020 | 84 | 0.160 |
Why?
|
| Genetic Therapy | 2 | 2015 | 679 | 0.160 |
Why?
|
| Pseudomonas Phages | 1 | 2019 | 10 | 0.160 |
Why?
|
| Bleomycin | 1 | 2019 | 150 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 473 | 0.150 |
Why?
|
| Anti-Infective Agents | 1 | 2021 | 266 | 0.150 |
Why?
|
| Phagocytosis | 1 | 2019 | 165 | 0.150 |
Why?
|
| Regeneration | 1 | 2020 | 202 | 0.150 |
Why?
|
| Herniorrhaphy | 1 | 2018 | 80 | 0.150 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 264 | 0.140 |
Why?
|
| Humans | 20 | 2023 | 123265 | 0.140 |
Why?
|
| Cytokines | 2 | 2020 | 1282 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2020 | 2316 | 0.140 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 186 | 0.140 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 364 | 0.140 |
Why?
|
| Organ Culture Techniques | 2 | 2014 | 154 | 0.140 |
Why?
|
| Female | 11 | 2023 | 65619 | 0.130 |
Why?
|
| Macrophages | 1 | 2020 | 604 | 0.130 |
Why?
|
| Receptors, Notch | 1 | 2018 | 204 | 0.130 |
Why?
|
| Actins | 1 | 2018 | 340 | 0.130 |
Why?
|
| Cell Survival | 1 | 2018 | 806 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 351 | 0.130 |
Why?
|
| Intestines | 1 | 2020 | 571 | 0.130 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 4298 | 0.130 |
Why?
|
| Placental Insufficiency | 1 | 2015 | 13 | 0.120 |
Why?
|
| Transduction, Genetic | 2 | 2013 | 289 | 0.120 |
Why?
|
| Myocardium | 1 | 2020 | 986 | 0.120 |
Why?
|
| Allergens | 1 | 2017 | 249 | 0.120 |
Why?
|
| Sex Factors | 1 | 2018 | 1265 | 0.120 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 61 | 0.110 |
Why?
|
| Capillaries | 2 | 2011 | 66 | 0.110 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 967 | 0.110 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2018 | 395 | 0.110 |
Why?
|
| Palate | 1 | 2013 | 12 | 0.110 |
Why?
|
| Algorithms | 1 | 2020 | 1598 | 0.110 |
Why?
|
| Mouth Mucosa | 1 | 2013 | 51 | 0.110 |
Why?
|
| Skin Physiological Phenomena | 1 | 2013 | 19 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2015 | 804 | 0.100 |
Why?
|
| Fetal Growth Retardation | 1 | 2015 | 224 | 0.100 |
Why?
|
| Saliva | 1 | 2013 | 113 | 0.100 |
Why?
|
| Mice, Knockout | 3 | 2015 | 3727 | 0.100 |
Why?
|
| Parvoviridae Infections | 1 | 2012 | 36 | 0.100 |
Why?
|
| Viral Tropism | 1 | 2012 | 42 | 0.100 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 254 | 0.100 |
Why?
|
| Fetal Therapies | 1 | 2012 | 72 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2018 | 625 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 393 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1232 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2011 | 117 | 0.090 |
Why?
|
| Ointments | 2 | 2021 | 13 | 0.090 |
Why?
|
| Placenta | 1 | 2015 | 491 | 0.090 |
Why?
|
| Trachea | 1 | 2012 | 201 | 0.090 |
Why?
|
| Endothelium, Vascular | 2 | 2011 | 516 | 0.090 |
Why?
|
| Child Development | 1 | 2013 | 260 | 0.090 |
Why?
|
| Male | 6 | 2021 | 60335 | 0.090 |
Why?
|
| Cystic Fibrosis | 1 | 2012 | 257 | 0.080 |
Why?
|
| Biomarkers | 2 | 2015 | 2953 | 0.080 |
Why?
|
| Apoptosis | 1 | 2015 | 1787 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2020 | 3020 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2011 | 529 | 0.070 |
Why?
|
| Coculture Techniques | 2 | 2023 | 233 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2021 | 570 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2020 | 8114 | 0.060 |
Why?
|
| Collagen Type VII | 1 | 2023 | 1 | 0.050 |
Why?
|
| Chorion | 1 | 2023 | 8 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2023 | 182 | 0.050 |
Why?
|
| Pseudomonas | 1 | 2022 | 11 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 1687 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2017 | 674 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 261 | 0.050 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2020 | 26 | 0.040 |
Why?
|
| Fetus | 2 | 2015 | 575 | 0.040 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2020 | 16 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 237 | 0.040 |
Why?
|
| Immunocompetence | 1 | 2019 | 33 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 221 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 791 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2015 | 12170 | 0.040 |
Why?
|
| Abdomen | 1 | 2020 | 129 | 0.040 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2019 | 18 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2019 | 45 | 0.040 |
Why?
|
| Uterus | 1 | 2023 | 594 | 0.040 |
Why?
|
| Immunity | 1 | 2019 | 179 | 0.040 |
Why?
|
| Models, Animal | 1 | 2020 | 466 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 388 | 0.040 |
Why?
|
| Kinetics | 1 | 2020 | 1318 | 0.040 |
Why?
|
| Interferons | 1 | 2019 | 122 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 458 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 429 | 0.040 |
Why?
|
| Swine | 1 | 2021 | 1167 | 0.040 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 66 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2017 | 53 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 454 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 2017 | 54 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 667 | 0.030 |
Why?
|
| Protein Transport | 1 | 2017 | 367 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 307 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 261 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 280 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 999 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2020 | 501 | 0.030 |
Why?
|
| Middle Aged | 1 | 2014 | 26089 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2017 | 402 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 709 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 419 | 0.030 |
Why?
|
| Submandibular Gland | 1 | 2013 | 7 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 2002 | 0.030 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2013 | 5 | 0.030 |
Why?
|
| Adult | 1 | 2014 | 29100 | 0.030 |
Why?
|
| Pneumonia | 1 | 2017 | 325 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 1290 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2013 | 81 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2019 | 1140 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 94 | 0.030 |
Why?
|
| Integrin beta3 | 1 | 2011 | 26 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6030 | 0.020 |
Why?
|
| Materials Testing | 1 | 2011 | 73 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 261 | 0.020 |
Why?
|
| Pregnancy | 2 | 2015 | 7129 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 16069 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2398 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 144 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2011 | 74 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 206 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 2854 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 767 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2011 | 196 | 0.020 |
Why?
|
| Heart | 1 | 2015 | 723 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 315 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2398 | 0.020 |
Why?
|
| Cell Communication | 1 | 2010 | 166 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 1613 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1916 | 0.020 |
Why?
|
| Gestational Age | 1 | 2013 | 1137 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 19127 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 941 | 0.020 |
Why?
|
| Liver | 1 | 2015 | 1743 | 0.020 |
Why?
|
| Child | 2 | 2020 | 24256 | 0.020 |
Why?
|
| Aged | 1 | 2023 | 19196 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 6223 | 0.010 |
Why?
|
| Infant | 1 | 2013 | 12376 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 13918 | 0.010 |
Why?
|